Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Glaxo Wellcome researches MMP inhibitors

March 17, 1998

Inhibitors of selectin binding and cell adhesion prepared at Nippon Shinyaku

March 17, 1998

Favorable results obtained with Enbrel combination in RA

March 16, 1998

Procter & Gamble reports novel NSAIDs with improved GI safety

March 16, 1998

Celgene expands phase I trial of TNF-alpha inhibitor

March 16, 1998

A new hypothesis may explain the high incidence of autoimmune disorders in women

March 13, 1998

P&U scientists disclose new MMP inhibitors for connective tissue diseases

March 12, 1998

Biomatrix and Novartis sign distribution agreement for Synvisc

March 11, 1998

New indication for Mobic cleared by U.K. authorities

March 6, 1998

AnervaX peptide vaccine successfully completes phase IIa trial

March 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...